UnitedHealth Group (NYSE:UNH) had its price target upped by investment analysts at Royal Bank of Canada from $269.00 to $280.00 in a report issued on Wednesday, The Fly reports. The firm currently has an “outperform” rating on the healthcare conglomerate’s stock. Royal Bank of Canada’s target price would indicate a potential upside of 15.15% from the stock’s current price.

Other analysts have also issued research reports about the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a research note on Thursday, September 21st. Citigroup increased their target price on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and issued a $208.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 17th. Finally, Jefferies Group increased their target price on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $241.30.

UnitedHealth Group (NYSE UNH) traded up $4.73 during mid-day trading on Wednesday, reaching $243.16. The company’s stock had a trading volume of 6,234,000 shares, compared to its average volume of 3,634,767. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $243.90. The stock has a market capitalization of $234,070.00, a price-to-earnings ratio of 22.70, a price-to-earnings-growth ratio of 1.45 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same quarter last year, the firm posted $2.11 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. equities research analysts forecast that UnitedHealth Group will post 12.2 earnings per share for the current fiscal year.

In related news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now directly owns 36,989 shares in the company, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the stock. Regal Wealth Group Inc. boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after acquiring an additional 4 shares in the last quarter. Highland Private Wealth Management boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after acquiring an additional 13 shares in the last quarter. RNC Capital Management LLC boosted its holdings in UnitedHealth Group by 0.7% in the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after acquiring an additional 13 shares in the last quarter. Finally, Flagship Harbor Advisors LLC boosted its holdings in UnitedHealth Group by 0.3% in the second quarter. Flagship Harbor Advisors LLC now owns 5,028 shares of the healthcare conglomerate’s stock worth $939,000 after acquiring an additional 15 shares in the last quarter. 86.09% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group (UNH) Price Target Increased to $280.00 by Analysts at Royal Bank of Canada” was reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.watchlistnews.com/unitedhealth-group-unh-price-target-increased-to-280-00-by-analysts-at-royal-bank-of-canada/1814063.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.